Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation-Reference-Cited by-同舟云学术

Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation

Published:2010-11-03 Issue:1 Volume:17 Page:77-88
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tawara Isao,Koyama Motoko,Liu Chen,Toubai Tomomi,Thomas Dafydd,Evers Rebecca,Chockley Peter,Nieves Evelyn,Sun Yaping,Lowler Kathleen P.,Malter Chelsea,Nishimoto Norihiro,Hill Geoffrey R.,Reddy Pavan

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconstituted CD74+ NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation;Journal of Autoimmunity;2024-07

2. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease;Journal of Clinical Investigation;2024-04-25

3. Immunomodulation by juglone alleviates acute graft‐versus‐host disease without compromising the graft‐versus‐leukaemia activity in mice;British Journal of Pharmacology;2024-04-07

4. Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model;International Journal of Molecular Sciences;2024-01-23

5. Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice;Clinical & Translational Immunology;2024-01